PERSISTENT EFFECTS OF (+/-)3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA, ECSTASY) ON HUMAN SLEEP

被引:89
|
作者
ALLEN, RP
MCCANN, UD
RICAURTE, GA
机构
[1] NIMH, BIOL PSYCHIAT BRANCH, ANXIETY & AFFECT DISORDERS SECT, BLDG 10, BETHESDA, MD 20892 USA
[2] JOHNS HOPKINS UNIV, SCH MED, FRANCIS SCOTT KEY MED CTR, DEPT NEUROL, BALTIMORE, MD 21205 USA
来源
SLEEP | 1993年 / 16卷 / 06期
关键词
MDMA; SEROTONIN; NEUROTOXICITY; AMPHETAMINES; SLEEP;
D O I
10.1093/sleep/16.6.560
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
(+/-)3,4-methylenedioxymethamphetamine (MDMA) is a recreational drug of abuse which damages serotonin neurons in animals. It is not known whether MDMA is also neurotoxic in humans, and if so, whether there are functional consequences. Given the putative role of serotonin in sleep, it was hypothesized that one manifestation of serotonin neurotoxicity in humans might be disturbances of sleep. To determine whether MDMA use has effects on sleep, all-night polysomnograms of 23 MDMA users were compared to those of 22 age- and sex-matched controls. On average, MDMA users had 19 minutes less total sleep and 23.2 minutes less non-REM (NREM) sleep than controls. These statistically significant differences in NREM sleep were due primarily to an average of 37 minutes less stage 2 sleep, with no significant differences noted in stages 1, 3 or 4. Although it is not known whether the alterations in sleep observed in MDMA users are due to serotonin neurotoxicity, the present findings suggest that MDMA use can lead to persistent changes in CNS structures involved in human sleep generation.
引用
收藏
页码:560 / 564
页数:5
相关论文
共 50 条
  • [1] Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy
    Parrott, AC
    JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (01) : 71 - 83
  • [2] Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)?
    Allott, Kelly
    Redman, Jennifer
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2007, 31 (03) : 327 - 347
  • [3] Altered pain responses in abstinent (±)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users
    McCann, Una D.
    Edwards, Robert R.
    Smith, Michael T.
    Kelley, Kristen
    Wilson, Michael
    Sgambati, Francis
    Ricaurte, George
    PSYCHOPHARMACOLOGY, 2011, 217 (04) : 475 - 484
  • [4] Altered pain responses in abstinent (±)3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users
    Una D. McCann
    Robert R. Edwards
    Michael T. Smith
    Kristen Kelley
    Michael Wilson
    Francis Sgambati
    George Ricaurte
    Psychopharmacology, 2011, 217 : 475 - 484
  • [5] A review on the mitochondrial toxicity of "ecstasy" (3,4-methylenedioxymethamphetamine, MDMA)
    Capela, Joao Paulo
    Carvalho, Felix Dias
    CURRENT RESEARCH IN TOXICOLOGY, 2022, 3
  • [6] 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment
    Logan, BK
    Couper, FJ
    JOURNAL OF FORENSIC SCIENCES, 2001, 46 (06) : 1426 - 1433
  • [7] Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)
    Taurah, Lynn
    Chandler, Chris
    Sanders, Geoff
    PSYCHOPHARMACOLOGY, 2014, 231 (04) : 737 - 751
  • [8] False-Positive Amphetamine/Ecstasy (MDMA/3,4-Methylenedioxymethamphetamine) (CEDIA) and Ecstasy (MDMA/3,4-Methylenedioxymethamphetamine) (DRI) Test Results With Fenofibrate
    Kaplan, Yusuf Cem
    Erol, Almila
    Karadas, Baris
    THERAPEUTIC DRUG MONITORING, 2012, 34 (05) : 493 - 495
  • [9] Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy") but not by fenfluramine
    Dafters, RI
    Lynch, E
    PSYCHOPHARMACOLOGY, 1998, 138 (02) : 207 - 212
  • [10] ASSESSMENT OF THE DISCRIMINATIVE STIMULUS EFFECTS OF THE OPTICAL ISOMERS OF ECSTASY (3,4-METHYLENEDIOXYMETHAMPHETAMINE, MDMA)
    BAKER, LE
    BROADBENT, J
    MICHAEL, EK
    MATTHEWS, PK
    METOSH, CA
    SAUNDERS, RB
    WEST, WB
    APPEL, JB
    BEHAVIOURAL PHARMACOLOGY, 1995, 6 (03): : 263 - 275